Abstract Details

Title National Trends in Utilization of Therapeutic Hypothermia for Cardiac Arrest: National Inpatient Sample Study 2008-2014

Topic Neuro Trauma, Critical Care, and Sports Neurology

Presentation(s) P2 - Poster Session 2 (5:30 PM-6:30 PM)

Poster/Presentation
Number 4-070

Objective

This study investigates trends in TH use for in and out-ofhospital cardiac arrest, and hospital factors associated with its use

Background Therapeutic hypothermia (TH) in cardiac arrest is underused in the United States. A better understanding of its utilization could inform future efforts and policies to improve adoption of the treatment.

Design/Methods We performed a crosssectional analysis using the Nationwide Inpatient Sample (NIS), 2008–2014, of US adult hospitalizations with cardiac arrest. Annual rate of TH use was calculated using NIS weighting. We identified our CA patient subset from using codes (DX1 = 427.5) and with a diagnosis or procedure code for TH (ICD-9 780.65, procedure code 99.81) from the International Classification of Diseases, 9th edition. Potential factors associated with increased/decreased likelihood of TH utilization were assessed using logistic regression

Results Of 1,160,431hospitalized patients with CA, 38422 were treated with TH (3.31%).
Across 2008–2014, 3.31% of cardiac arrest patients received TH; increasing from 0.72% (2008) to 4.35% (2014).Signi?cant factors associated with higher TH utilization were: large hospitals urban, location, Northeast or West regions, median household income above 50th percentile.
Signi?cant factors associated with lower likehood of TH utilization were female gender, Hispanic race/ethnicity and Age ≥ 65 yrs.

Conclusions Utilization of TH in cardiac arrest remains low, but increased six-fold from 2008 to 2014. The signi?cant variability in implementation of TH, argues for nationwide best practices or regionalization of postcardiac arrest care hospitals.

Authors/Disclosures
PRESENTER	No disclosure on file
Mohammad Rauf A. Chaudhry, MD	Dr. Chaudhry has nothing to disclose.
Ihtesham A. Qureshi, MD	No disclosure on file
Harathi Bandaru, MD	Dr. Bandaru has nothing to disclose.
Shayan Ul Haque, MD, MBBS	No disclosure on file
Michael A. Castellano, MD (UF Health Jacksonville)	No disclosure on file
	No disclosure on file
Paisith Piriyawat, MD (Texas Tech University)	Dr. Piriyawat has nothing to disclose.
Rakesh Khatri, MD, FAAN	Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Alpha insight . Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Survey company .
Alberto Maud, MD (Paul L. Foster School of Medicine Texas Tech UHSC El Paso, Texas)	Dr. Maud has nothing to disclose.
Darine Kassar, MD	Dr. Kassar has nothing to disclose.
Gustavo J. Rodriguez, MD (Gustavo J. Rodriguez)	Dr. Rodriguez has nothing to disclose.
Salvador Cruz-Flores, MD, FAAN (Paul L. Foster School of Medicine Texas Tech University Health Sciences Center)	The institution of Dr. Cruz-Flores has received research support from University of Texas System.

��ɫ��

��ɫ��